云南鸿翔一心堂药业（集团）股份有限公司 投资者电话会议记录 时间：2015 年 8 月 15 日 地点：云南鸿翔一心堂药业（集团）股份有限公司会议室 召开方式：电话访谈交流 投资者：国泰君安等 94 人 接待人：公司董事、 董事会秘书、副总裁、财务负责人 田俊 参加人员： 2015 年 8 月 10 日，一心堂发布中报，公司上半年营业收入 24.99 亿 元，增长 20.5%，归母净利润 1.74 亿，同比增长 10.44%，为方便 投资者深入了解公司经营情况及未来战略，我们特召开电话会议，邀 请公司 CFO 兼董秘田俊总为大家解读公司中报及并购进展内容，会议 核心要点如下： 一、一心堂上半年整体业绩情况： 截止到 2015 年 6 月 30 日： 营业收入 24.99 亿元，相较于 2014 年 20.73 亿元，增长 20.5% 净利润是 1.739 亿元，相较于 2014 年 1.571 亿元，增长 10.43% 总资产 37 亿，2014 年 29 亿，归属上市公司母公司净资产 21 亿， 2014 年 20.8 亿 二、公司营业收入增长情况分析 门店的成长的规律是，前 3 年是迅速成长，3-6 年缓 ...

云南鸿翔一心堂药业（集团）股份有限公司 投资者调研会议记录 尊敬的各位投资者大家晚上好，非常感谢大家利用休息的时间参加 后续会留出时间给各位投资者进行提问。 时间：2015 年 8 月 17 日 地点：云南鸿翔一心堂药业（集团）股份有限公司会议室 召开方式：电话访谈交流 投资者：兴业证券等 54 人 接待人：公司董事、 董事会秘书、副总裁、财务负责人 田俊 参加人员：证券副总监李正红 徐佳熹： | --- | |--------------------------------------------------------------| | | | 兴业医药-一心堂中报电话会议，我是兴业医药徐佳熹，和我一起主 | | 持这次会议的还有我们医药组的分析师孙媛媛。众所周知，一心堂自 | | 四月份停牌之后，公告不断，包括了并购、成立产业基金、定增以及 | | 中报发布，最近公司有公告了员工持股的计划，为了让我们的投资 | | 者更好的了解公司的经营情况，我们特意邀请到了公司的两位领导， | | 分别是公司的董事会秘书田俊田总以及证券副总监李正红总跟各位 | | 投资者进行交流。当然因为公司的停牌时间较长，期间公告 ...

Group 1: Meeting Overview - The meeting was held on August 17, 2015, from 19:30 to 21:30 [1] - Participants included 54 individuals from various investment firms [1] - The main focus was on the company's mid-year report and developments during the trading suspension [1] Group 2: Participants - Key representatives included Tian Jun from Yixin Tang and multiple analysts from Industrial Securities [3][5][6] - Notable participants also included representatives from various investment funds and asset management companies [4][6] Group 3: Company Information - The meeting was conducted by the board secretary and financial head, Tian Jun [1] - The company discussed its performance and strategic direction during the call [1]

投资者关系活动记录表 证券代码：002727 证券简称：一心堂 云南鸿翔一心堂药业（集团）股份有限公司投资者关系活动记录表 | --- | --- | --- | |-----------------------------|-------------------------------------|-----------------------------------------------| | | | | | 投资者关系活动 | ■ | 特定对象调研 □分析师会议 | | 类别 | □ | 媒体采访 □业绩说明会 | | | □ | 新闻发布会 □路演活动 | | | ■ 现场参观 | | | | □ 其他 （电话会议） | | | 参与单位名称及 | | 中欧基金 江琦、东方证券 李峰、国投瑞银 潘天奇 | | 人员姓名 | | | | 时间 | 2015 年 6 月 25 | 日 16:00-17:00 | | 地点 | | 云南鸿翔一心堂药业（集团）股份有限公司会议室 | | 上市公司接待人 | 证券事务代表 证券总监 代四顺 | | | | | | | 员姓名 | 财务副总监 肖冬磊 证券副总监 ...

Group 1: Investor Relations Activity - The activity involved a specific audience survey and a site visit [1] - Participants included representatives from Guotai Junan, GF Fund, and other investment firms totaling 32 individuals [1] - The event took place on August 28, 2015, from 14:00 to 16:30 [3] Group 2: Company Representatives - The reception was conducted by the Chairman, President, Secretary of the Board, and other senior executives [1] - Key personnel included Chairman Ruan Hongxian, President Zhao Biao, and Secretary of the Board Tian Jun [1] Group 3: Main Content of the Activity - The main focus was on business development discussions and a site tour of the company [1]

Group 1: Store Layout Planning - The company has over 2,000 retail pharmacies covering all cities and counties in Yunnan Province, enhancing consumer recognition and brand acceptance [2] - As of March 31, 2015, the company and its wholly-owned subsidiaries operated a total of 2,786 direct chain stores [2] - The strategic focus is on high-density store placement in core areas, expanding from Yunnan to the Southwest and nationwide, complemented by e-commerce initiatives [2] Group 2: Membership Management - The company is implementing a CRM system for comprehensive customer lifecycle management, aiming to enhance customer loyalty both online and offline [3] - As of March 31, 2015, the company recorded over 10 million membership entries, with more than 7 million active members [4] - The CRM system supports data management and analysis to improve marketing and sales interactions with customers [4] Group 3: E-commerce Development - The company is building an O2O (Online to Offline) marketing network and has established an e-commerce department [5] - A big data platform (BW, HANA) is being developed to analyze consumer behavior and support both online and offline business operations [5] Group 4: Mergers and Acquisitions - The company has announced several acquisitions, including Hainan Guang'an Tang and various pharmacies in Shanxi, reflecting its strategy to expand from Yunnan to the Southwest and beyond [5] - The company aims to leverage its store quantity advantage in Yunnan while actively exploring new openings and partnerships in other provinces [5]

Group 1: Investor Relations Activity - The activity involved specific object research and included participants from various financial institutions [1] - The meeting took place on June 24, 2015, from 11:00 AM to 12:00 PM [1] - The location of the meeting was the Yixin Tang company conference room [1] Group 2: Participants - Participants included representatives from China Trust Commercial Bank, Fuhua Investment Trust, and Unified Investment Trust [1] - Notable attendees were Li Zhenyi, Yu Wenyue, Lin Ziqin, and Chen Chaozheng [1] - The company was represented by the board of directors, board secretary, vice president, and financial head Tian Jun [1] Group 3: Meeting Content - The main content of the investor relations activity focused on the exchange of information regarding the company's and industry’s development [1] - Attachments included meeting minutes and a list of participating units [1]

Group 1: Investor Relations Activity - The activity involved a specific object survey and a site visit [1] - Participants included Guangfa Fund Management Co., Ltd. represented by Liu Xiaolong [1] - The event took place on July 3, 2016, from 13:00 to 14:30 [1] Group 2: Company Representatives - Company representatives included CEO Zhao Biao, Secretary of the Board and Financial Officer Tian Jun, and Deputy Director of Securities Li Zhenghong [1] Group 3: Meeting Content - The main content of the investor relations activity focused on business communication [1] - Meeting notes were provided as an attachment [1]

云南鸿翔一心堂药业（集团）股份有限公司 投资者调研会议记录 时间：2016 年 7 月 11 日 地点：云南鸿翔一心堂药业（集团）股份有限公司昆明总部 召开方式：电话会议 投资者：兴业证券徐佳熹、兴业证券孙媛媛、北京鼎萨投资陈斯扬、 海富通基金宋硕等投资者 88 人 接待人：总裁赵飚、董秘兼财务负责人田俊 参加人员：证券副总监李正红 问题一：请田总简单介绍一下公司近期的情况 ？ 答：我们预计在 8 月 16 号披露中期报告，按照规定 7 月 16 号就不能进行任何投资者 接待和交流活动。我们预测中报业绩在 1.74 亿到 2.26 亿之间，1.74 个亿是去年的中报的 业绩，业绩增幅是 0%到 30%。关注一心堂的朋友都知道，一心堂一季报披露以后都比较 稳定，各方面的情况进展也是良好的。最近我们也披露了一些投资者关系的管理情况，包 括一些机构来云南调研，对云南药店的发展情况做了肯定和评价。一心堂这上市两年，一 直都很透明，大家对一心堂的评价也很正面。最近一些情况我们秉承积极开放的态度和大 家交流，有两件事我要对大家做一个解释： 1、罗总（罗永斌）股票减持情况，罗总的这次减持 87.84 万股，已做过减持的提示 ...

云南鸿翔一心堂药业（集团）股份有限公司 投资者调研会议记录 时间：2016 年 7 月 6 日 地点：山西鸿翔一心堂药业有限公司总部 召开方式：现场交流 投资者：创金合信皮劲松、博道投资张斌、高瓴资本徐睿、长信基 金张子乔、华商基金张晓、汇添富张玮、平安资产黄文锋、上海建 信资本周琦、西部证券朱镭、国海证券盛丽华、玺萌财富董丽蒙、 国信证券万明亮 接待人：山西鸿翔一心堂药业有限公司总经理张经伟 参加人员：行政副总赵合群、财务总监李晓龙、人力总监郝晓晴 问题一.收购交接后公司经营方面有了哪些发展和改善 答：1）公司企业文化、人员、相关制度、流程、远程管理得到了很大的提升和改善， 规范性更强、责权利更清晰、运转效率越高； 2）团队融入快，配合良好，大家都能高度认同公司发展模式，都能团结一心、共同 进步，共同创造更好的业绩； 3）借助并购商品资源优势、供应商资源优势、规模化优势，并购团队人员优势，大 幅扩充公司商品线、品种更全、能很好的满足老百姓不同的用药和健康需求，借助品牌供 应商、大供应商政策资源，更好的扩大公司品牌宣传、占领市场份额，同时把品质好、质 量优、价格优、实惠让利给顾客，真正的让老百姓得到实惠的健康 ...